Search Result "BT474"
Targeting EGFR and HER2 with 211At-Labeled Molecules: Unexpected and Expected Dose-Effect Relations in Cultured Tumor Cells
Journal: Current Radiopharmaceuticals
Volume: 1 Issue: 3 Year: 2008 Page: 225-233
Author(s): J. Carlsson, A. C. Steffen, A. L. Sundberg, M. Vikstrom, A. Orlova, L. Gedda, B. Stenerlow, H. Lundqvist, V. Tolmachev
Targeting Bcl-2 in Herceptin-Resistant Breast Cancer Cell Lines
Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 9 Issue: 3 Year: 2011 Page: 184-190
Author(s): Anatasha Crawford, Rita Nahta
Ras-Induced Resistance to Lapatinib is Overcome by MEK Inhibition
Journal: Current Cancer Drug Targets
Volume: 10 Issue: 2 Year: 2010 Page: 168-175
Author(s): G. Zoppoli, E. Moran, D. Soncini, M. Cea, A. Garuti, I. Rocco, G. Cirmena, V. Grillo, L. Bagnasco, G. Icardi, F. Ansaldi, S. Parodi, F. Patrone, A. Ballestrero, A. Nencioni
Dynamic Simulations of Pathways Downstream of ERBB-Family, Including Mutations and Treatments: Concordance with Experimental Results
Journal: Current Cancer Drug Targets
Volume: 10 Issue: 7 Year: 2010 Page: 737-757
Author(s): N. Castagnino, L. Tortolina, A. Balbi, R. Pesenti, R. Montagna, A. Ballestrero, D. Soncini, E. Moran, A. Nencioni, S. Parodi
A Small-molecule Inhibitor, 5-O-Tritylthymidine, Targets FAK and Mdm-2 Interaction, and Blocks Breast and Colon Tumorigenesis in vivo
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13 Issue: 4 Year: 2013 Page: 532-545
Author(s): Vita M. Golubovskaya, Nadia L. Palma, Min Zheng, Baotran Ho, Andrew Magis, David Ostrov, William G. Cance
Inhibition of Membrane Complement Inhibitor Expression (CD46, CD55, CD59) by siRNA Sensitizes Tumor Cells to Complement Attack
Ebook: Advances in Cancer Drug Targets
Volume: 3 Year: 2016
Author(s): Srinivas Mamidi,Simon Höne,Nicolas Geis,Stefanie Zell,Renate Rutz,Wenhan Li,Thomas Giese,Stefan Schultz,Michael Kirschfink
Doi: 10.2174/9781681082332116030004
EGFR Kinase Inhibiting Amino-enones for Breast Cancer; CADD Approach
Journal: Current Computer-Aided Drug Design
Volume: 20 Issue: 0 Year: 2024 Page: 1-10
Author(s):
Anticancer Effects of Novel Tetrahydro-Dimethyl-Xanthene-Diones
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 20 Issue: 7 Year: 2020 Page: 909-916
Author(s): Alagumuthu Manikandan,Arumugam Sivakumar,Poonam S. Nigam,Ayyakannu A. Napoleon
Inhibition of Membrane Complement Inhibitor Expression (CD46, CD55, CD59) by siRNA Sensitizes Tumor Cells to Complement Attack In Vitro
Journal: Current Cancer Drug Targets
Volume: 10 Issue: 8 Year: 2010 Page: 922-931
Author(s): N. Geis, S. Zell, R. Rutz, W. Li, T. Giese, S. Mamidi, S. Schultz, M. Kirschfink
Recent Insights into the Development of Preclinical Trastuzumab- Resistant HER2+ Breast Cancer Models
Journal: Current Medicinal Chemistry
Volume: 25 Issue: 17 Year: 2018 Page: 1976-1998
Author(s): Paula Gonzalez-Alonso,Ion Cristobal,Sandra Zazo,Ester Martin-Aparicio,Cristina Chamizo,Juan Madoz-Gurpide,Ana Rovira,Pilar Eroles,Ana Lluch,Joan Albanell,Federico Rojo